Clinical trial Recruiting at 1 site Interventional Ages 60 and up

Oral7 Mouth Spray for dry mouth in older adults

Official title: Effect of Enzymatic-Containing Mouth Spray (Oral7®) on Xerostomia Symptoms, Salivary Flow Rate, and Oral Health-Related Quality of Life in Older Patients: A Randomised Placebo-Control Trial

Run by Mbd Marketing Sdn. Bhd. · NCT06984848 · Data updated 2026-11-12

This test checks if Oral7 mouth spray can ease dry mouth and improve saliva flow and quality of life in people aged 60 and up with xerostomia.

More Geriatric trials

Quick facts

Study typeInterventional
Ages60 Years and up
SexAll
Enrollment100 (estimated)
SponsorMbd Marketing Sdn. Bhd.
Industry-sponsored
Locations1 site (Kubang Kerian, Kelantan)
StatusRecruiting
StartedSeptember 18, 2025
Main results expectedDecember 1, 2026
Study endsMay 1, 2027
Registry record updatedMay 22, 2026
Trial IDNCT06984848 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 60 years and older with self-reported xerostomia who can use an oral spray and speak for assessments.

Probably not a fit

People without persistent dry mouth or those unable to use a spray consistently may not experience benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-center, randomized, double-blind, placebo-controlled study at Universiti Sains Malaysia to see if an enzymatic mouth spray called Oral7® helps with xerostomia in older adults. Participants aged 60+ with self-reported dry mouth will use Oral7® or placebo for four weeks. Primary outcome is the change in a xerostomia symptom score, with secondary measures including unstimulated salivary flow rate and oral-health-related quality of life. The study uses natural enzymes and other ingredients in the spray and compares outcomes between the active and placebo groups. Enrollment spans August 2025 to July 2026 and excludes individuals with recent salivary substitutes or conditions requiring urgent oral care.

Why it matters

Potential benefit: If successful, patients may experience reduced dry mouth symptoms and improved oral health-related quality of life.

How similar studies have gone: Previous studies in similar enzymatic or saliva-supporting products have shown potential benefit for xerostomia, though this exact formulation is novel in this setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Aged 60 years and above
* Patients with often or always having dry mouth/xerostomia by asking single-item xerostomia question: "How often does your mouth feel dry?" (Adakah mulut anda sering merasakan kekeringan?). The response options were "Never (Tidak Pernah)," "Sometimes (Kadang-kadang)," "Often (Kerap)," or "Always (Sentiasa/Sepanjang masa)."
* Patients who are taking nutrition orally
* Patients who are able to speak
* Patients who are physically fit to take oral spray on their own.

Exclusion Criteria:

* • Patients on salivary substitutes for the past one week

  * Oral condition that required immediate attention such as mucosal or gingival bleeding, orofacial swelling, oral pain and oral ulcer.
  * Patients who are deaf and mute
  * Those with mental disabilities or documented cognitive deficits that would impair their ability to answer questions independently.

Where it's running

  • Universiti Sains Malaysia
    Kubang Kerian, Kelantan, Malaysia
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.